Gene therapy. RAC hears a plea for resuming trials, despite cancer risk.
Kaiser
Jocelyn
J
D000328:Adult; D026683:Advisory Committees; D002648:Child; D002986:Clinical Trials as Topic; D004274:DNA, Recombinant; D005602:France; D040181:Genetic Diseases, X-Linked / Q000628:therapy; D015316:Genetic Therapy / Q000009:adverse effects*; D005822:Genetic Vectors; D006801:Humans; D015458:Leukemia, T-Cell / Q000209:etiology*; D008297:Male; D009369:Neoplasms / Q000628:therapy; D012190:Retroviridae / Q000235:genetics; D016511:Severe Combined Immunodeficiency / Q000628:therapy; D014481:United States
D004274:DNA, Recombinant